Source: University of Rochester Medical Center
Date: March 4, 2008
Summary:
Researchers have learned more about how a leading drug prevents certain types of arthritis from eating away at bone. Precursors to bone-eating cells are a likely target of next-generation arthritis treatments. The findings may soon enable physicians to tell patients quickly whether or not they will respond to current therapies. In addition, the findings may help with the design of new drugs that prevent arthritis-related bone loss, but with fewer side effects.
